Targeting a helix-in-groove interaction between E1 and E2 blocks ubiquitin transfer
Ann M. Cathcart(Dana-Farber Cancer Institute), Loren D. Walensky(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Henry D. Herce(Technische Universität Darmstadt), Utsarga Adhikary(Dana-Farber Cancer Institute), Gregory H. Bird(Dana-Farber Cancer Institute), Thomas E. Wales(Northeastern University), Zachary J. Hauseman(Novartis (United States)), Michelle S. Prew(Massachusetts General Hospital), John R. Engen(Northeastern University), Susan Lee(New York Hospital Queens), Edward P. Harvey(Harvard University), Tun Oo(Dana-Farber Cancer Institute), Catherine E. Newman(Harvard University)
Cited by 8
Related Papers
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
|Nature|2016|2.7k
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
|Nature|2015|1.7k
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells
|Nature Biotechnology|2016|714
Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition
|Nature Biotechnology|2015|630
Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding
|Molecular & Cellular Proteomics|2010|393